LRRK2 G2019S carriers have less tremor than noncarriers do as first symptom (26.8% versus 52.5%, corrected-p = 0.03) and exhibited less of the tremor-dominant phenotype than noncarriers (corrected-p = 0.009). Here, LRRK2 is linked to Tremor.